Research Reports
- 3/7/2024
New THIO-101 Update Shows Consistent Overall Response Rate
- 2/23/2024
THIO-101 Patient Enrollment Completed Ahead Of Schedule
- 2/8/2024
Journal Article Confirms MOA In An Additional Tumor Type
- 12/20/2023
MAIA Selects THIO Dose For Continued Studies In Non-Small Lung Cancer
- 10/25/2023
THIO-101 Data Update Shows Improved Disease Control Rates
- 10/16/2023
Journal Publishes THIO Data In Pediatric Brain Cancer Models
- 10/6/2023
THIO-101 To Add US Clinical Sites and Present Data At ESMO
- 8/9/2023
2Q23 Reported With Trial Enrollment Making Progress
- 7/11/2023
THIO-101 Part A Survival Data Reaches 12 Months
- 6/21/2023
Phase 2 THIO-101 Trial Reaches Recruitment Milestone
- 5/9/2023
1Q23 Reported As Trial Progress Continues
- 4/19/2023
Publication Details Efficacy and Mechanism In HCC Models